Stay updated on Safety of Single Dose UB-221 in Urticaria Clinical Trial

Sign up to get notified when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Single Dose UB-221 in Urticaria Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH-wide banner about updates to terminology during the agency’s transition from “Artificial Intelligence” to “Super Intelligence” was removed.
    Difference
    1%
    Check dated 2026-11-09T13:29:58.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T13:30:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    An NIH-wide announcement explains that agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T13:45:19.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:52:30.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the 403 error page is otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-12T14:20:03.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is not accessible at this time. The layout includes a minimal header, a Home link, and a Revision banner, reflecting an error state rather than the usual study details.
    Difference
    17%
    Check dated 2026-09-21T20:12:13.000Z thumbnail image

Stay in the know with updates to Safety of Single Dose UB-221 in Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Single Dose UB-221 in Urticaria Clinical Trial page.